This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (20)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Arch Pediatr Adolesc Med. 2001;155:95-96.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Unexpected and substantial increases in hospitalization rates as a result of acute bronchiolitis among infants and young children in the United States point to the growing public health burden of this disease. This was highlighted in a recent publication by Shay et al¹ using data from 1980 through 1996 from the National Hospital Discharge Survey. The authors reported increases in acute bronchiolitis hospitalization rates of 152% and 77% among infants and children aged 1 to 4 years, respectively. Based on their estimates that between 50% and 80% of these hospitalizations are attributable to infection with respiratory syncytial virus (RSV), the authors provided current annual estimates of RSV-associated bronchiolitis hospitalizations in the range of 51 240 to 81 985 among children younger than 1 year and 62 518 to 100 029 in children younger than 5 years. We felt that it would further enhance our understanding of the impact of RSV by estimating the costs . . . [Full Text of this Article]

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Direct Medical Costs of Bronchiolitis Hospitalizations in the United States
Pelletier et al.
Pediatrics 2006;118:2418-2423.
ABSTRACT | FULL TEXT  

Cost-effectiveness Analysis of Palivizumab in Premature Infants Without Chronic Lung Disease.
ElHassan et al.
Arch Pediatr Adolesc Med 2006;160:1070-1076.
ABSTRACT | FULL TEXT  

Diagnosis and Management of Bronchiolitis
Subcommittee on Diagnosis and Management of Bronch
Pediatrics 2006;118:1774-1793.
ABSTRACT | FULL TEXT  

Anti-Respiratory Syncytial Virus (RSV) Neutralizing Antibody Decreases Lung Inflammation, Airway Obstruction, and Airway Hyperresponsiveness in a Murine RSV Model
Mejias et al.
Antimicrob. Agents Chemother. 2004;48:1811-1822.
ABSTRACT | FULL TEXT  

Type 1 and Type 2 Cytokine Imbalance in Acute Respiratory Syncytial Virus Bronchiolitis
Legg et al.
Am. J. Respir. Crit. Care Med. 2003;168:633-639.
ABSTRACT | FULL TEXT  

Detection of Human Respiratory Syncytial Virus in Respiratory Samples by LightCycler Reverse Transcriptase PCR
Whiley et al.
J. Clin. Microbiol. 2002;40:4418-4422.
ABSTRACT | FULL TEXT  

The pathogenesis of respiratory syncytial virus disease in childhood
McNamara and Smyth
Br Med Bull 2002;61:13-28.
ABSTRACT | FULL TEXT